Involvement of Galectin-1 Tumor Microenvironment in

被引:0
|
作者
Chen, Yi-Fan [1 ]
Wang, Chung-Chi [1 ]
Hsu, Chieh-Ying [1 ]
Huang, Eng-Yen [1 ,2 ]
机构
[1] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, 129,Dapi Rd, Kaohsiung 83301, Taiwan
[2] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan
关键词
Galectin-1; tumor microenvironment; radiosensitivity; SQUAMOUS-CELL CARCINOMA; MACROPHAGE INFILTRATION; PROGNOSTIC IMPACT; PROSTATE-CANCER; IN-VITRO; GROWTH; RECURRENCE; HYPOXIA; STAGE; ANGIOGENESIS;
D O I
10.21873/anticanres.15007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The mechanisms of galectin-1 in radioresistance may not only involve intracellular but also extracellular effects because galectin-1 can be secreted into the extracellular matrix. We, therefore, aimed to investigate the role of the galectin-1 tumor microenvironment on radiosensitivity in a murine tumor model. Materials and Methods: Wild-type or stable galectin-1-down-regulated cancer cells (melanoma (B16F10) and lung cancer (LLC1)) were injected (subcutaneous injection) into wild-type or knockout (galectin-1, B cells, and T cells) mice that were subject to 0 or 8 Gy irradiation. Results: Galectin-1-down-regulated B16F10 cells showed increased radiosensitivity when injected into galectin-1 knockout mice. Interestingly, radioresistance of wild-type LCC1 tumors was noted when injected into galectin-1 and B cell knockout mice. However, radiosensitization was observed in T cell knockout mice with wild-type LCC1 cells. Conclusion: The role of endogenous galectin-1 in radioresistance exists in cases without extracellular galectin-1. Extracellular galectin-1 requires endogenous galectin-1 to radiosensitize tumors in mice.
引用
收藏
页码:2321 / 2331
页数:11
相关论文
共 50 条
  • [31] Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions
    Jeremy Bonzi
    Olivier Bornet
    Stephane Betzi
    Brian T. Kasper
    Lara K. Mahal
    Stephane J. Mancini
    Claudine Schiff
    Corinne Sebban-Kreuzer
    Francoise Guerlesquin
    Latifa Elantak
    Nature Communications, 6
  • [32] Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
    Thijssen, Victor L.
    Barkan, Batya
    Shoji, Hiroki
    Aries, Ingrid M.
    Mathieu, Veronique
    Deltour, Louise
    Hackeng, Tilman M.
    Kiss, Robert
    Kloog, Yoel
    Poirier, Francoise
    Griffioen, Arjan W.
    CANCER RESEARCH, 2010, 70 (15) : 6216 - 6224
  • [33] Taloside Inhibitors of Galectin-1 and Galectin-3
    Collins, Patrick M.
    Oberg, Christopher T.
    Leffler, Hakon
    Nilsson, Ulf J.
    Blanchard, Helen
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (03) : 339 - 346
  • [34] Galectin-1 and galectin-3 in chronic pancreatitis
    Wang, L
    Friess, H
    Zhu, ZW
    Frigeri, L
    Zimmermann, A
    Korc, M
    Berberat, PO
    Büchler, MW
    LABORATORY INVESTIGATION, 2000, 80 (08) : 1233 - 1241
  • [35] Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions
    Bonzi, Jeremy
    Bornet, Olivier
    Betzi, Stephane
    Kasper, Brian T.
    Mahal, Lara K.
    Mancini, Stephane J.
    Schiff, Claudine
    Sebban-Kreuzer, Corinne
    Guerlesquin, Francoise
    Elantak, Latifa
    NATURE COMMUNICATIONS, 2015, 6
  • [36] Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer
    Chung, Hyewon
    Gyu-mi, Park
    Na, Yi Rang
    Lee, Yun-Sang
    Choi, Hongyoon
    Seok, Seung Hyeok
    THERANOSTICS, 2024, 14 (02): : 843 - 860
  • [37] Involvement of Vascular Endothelial Growth Factor Receptors in Endothelial Cell Response to Galectin-1 and Galectin-3
    D'Haene, N.
    Sauvage, S.
    Maris, C.
    Trepant, A. L.
    Le Mercier, M.
    Decaestecker, C.
    Salmon, I.
    JOURNAL OF PATHOLOGY, 2011, 224 : S15 - S16
  • [38] The galectin-1 null mouse furthers the understanding of the role of galectin-1 in muscle formation, differentiation and regeneration
    Goldring, K
    Jones, GE
    Poirier, F
    Prasad, R
    Tavsanoglu, Y
    Watt, DJ
    NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 719 - 720
  • [39] Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels
    Chen, Suyu
    Chen, Kuangdee
    Lin, Yihsiu
    Wang, Ssuchia
    Yu, Huichuan
    Chang, Chaohsuan
    Cheng, Tingchun
    Hsieh, Chiaoyun
    Li, Jiayi
    Lai, Hsiaohsuan
    Chen, Denghai
    Huang, Chengpo
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 491
  • [40] Delineating the "galectin signature" of the tumor microenvironment
    Compagno, Daniel
    Laderach, Diego J.
    Gentilini, Lucas
    Jaworski, Felipe M.
    Rabinovich, Gabriel A.
    ONCOIMMUNOLOGY, 2013, 2 (04)